Vivos (RDGL) Change in Account Payables (2010 - 2019)
Vivos' (RDGL) quarterly Change in Account Payables came in at -$21600.0 in Q4 2019, up 81.73% year-on-year from -$11885.8 in Q4 2018, and down 264.57% quarter-over-quarter from $13125.0 in Q3 2019.
Vivos (RDGL) Change in Account Payables (2010 - 2019) Analysis & Trends
Vivos has disclosed Change in Account Payables across 10 years of filings, most recently posting -$21600.0 for Q4 2019.
- Change in Account Payables for Q4 2019 came in at -$21600.0, up 81.73% year-over-year; the trailing twelve-month figure through Dec 2019 was -$6500.0 (up 94.93% YoY), and the FY2019 annual result was -$6500.0, up 94.93% from the prior year.
- Change in Account Payables came in at -$21600.0 for Q4 2019 at Vivos, down from $13125.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $281077.0 in Q3 2016 to a low of -$170241.0 in Q1 2016.
- The 5-year median for Change in Account Payables is $902.0 (2018), against an average of $3373.1.
- Peak annual rise in Change in Account Payables reached 470.11% in 2016, while the deepest fall reached 528.22% in 2016.
- Vivos' Change in Account Payables stood at $103499.0 in 2015, then climbed by 10.8% to $114679.0 in 2016, then slumped by 165.09% to -$74647.0 in 2017, then sank by 58.38% to -$118223.0 in 2018, then soared by 81.73% to -$21600.0 in 2019.
- The last three Change in Account Payables figures came in at -$21600.0 (Q4 2019), $13125.0 (Q3 2019), and -$1525.0 (Q2 2019), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 56.90 Mn |
| 10 | Vivos | - | - | -3,105.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -21,600.00 |
| Dec 31, 2019 | -21,600.00 |
| Sep 30, 2019 | 13,125.00 |
| Sep 30, 2019 | 13,125.00 |
| Jun 30, 2019 | -1,525.00 |
| Jun 30, 2019 | -1,525.00 |
| Mar 31, 2019 | 3,500.00 |
| Mar 31, 2019 | 3,500.00 |
| Dec 31, 2018 | -118,223.00 |
| Dec 31, 2018 | -118,223.00 |
| Sep 30, 2018 | 3,329.00 |
| Sep 30, 2018 | 3,329.00 |
| Jun 30, 2018 | 4,025.00 |
| Jun 30, 2018 | 4,025.00 |
| Mar 31, 2018 | -17,309.00 |
| Mar 31, 2018 | -17,309.00 |
| Dec 31, 2017 | -74,647.00 |
| Dec 31, 2017 | -74,647.00 |
| Sep 30, 2017 | -17,723.00 |
| Sep 30, 2017 | -17,723.00 |